HSP90 inhibition has also been shown to preferentially induce apoptosis in KRAS-mutant colon cancer cells in vitro and in a colon cancer-derived xenograft model in nu/nu mice, indicating that this vulnerability might translate across different RAS-mutant tumor types (Wang et al., 2016). Here, KRAS is linked to malignant colon neoplasm.